Table 1.
INGENUITY Pathway Analysis | |
---|---|
Top Canonical Pathways | P Value |
Ethanol Degradation II | 4.01×10−5 |
Noradrenaline and Adrenaline Degradation | 5.09×10−5 |
Synaptic Long Term Potentiation | 6.33×10−5 |
Top Diseases | |
Metabolic Disease | 1.43×10−2 – 2.14×10−5 |
Cardiovascular Disease | 1.76×10−2 – 2.84×10−5 |
Neurological Disease | 1.79×10−2 – 1.42×10−5 |
Physiological System Development and Function | |
Renal and Urological System Development and Function | 1.25×10−2 – 1.41×10−4 |
Auditory and Vestibular System Development and Function | 1.79×10−2 – 3.27×10−4 |
Embryonic Development | 1.79×10−2 – 1.13×10−5 |
Organismal Development | 1.79×10−2 – 4.72×10−5 |
Hair and Skin Development and Function | 3.60×10−3 – 1.13×10−5 |